Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Cinnarizine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cinnarizine manufacturer or Cinnarizine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cinnarizine manufacturer or Cinnarizine supplier.
PharmaCompass also assists you with knowing the Cinnarizine API Price utilized in the formulation of products. Cinnarizine API Price is not always fixed or binding as the Cinnarizine Price is obtained through a variety of data sources. The Cinnarizine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cinnarizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cinnarizine, including repackagers and relabelers. The FDA regulates Cinnarizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cinnarizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cinnarizine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cinnarizine supplier is an individual or a company that provides Cinnarizine active pharmaceutical ingredient (API) or Cinnarizine finished formulations upon request. The Cinnarizine suppliers may include Cinnarizine API manufacturers, exporters, distributors and traders.
click here to find a list of Cinnarizine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cinnarizine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cinnarizine active pharmaceutical ingredient (API) in detail. Different forms of Cinnarizine DMFs exist exist since differing nations have different regulations, such as Cinnarizine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cinnarizine DMF submitted to regulatory agencies in the US is known as a USDMF. Cinnarizine USDMF includes data on Cinnarizine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cinnarizine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cinnarizine suppliers with USDMF on PharmaCompass.
A Cinnarizine CEP of the European Pharmacopoeia monograph is often referred to as a Cinnarizine Certificate of Suitability (COS). The purpose of a Cinnarizine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cinnarizine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cinnarizine to their clients by showing that a Cinnarizine CEP has been issued for it. The manufacturer submits a Cinnarizine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cinnarizine CEP holder for the record. Additionally, the data presented in the Cinnarizine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cinnarizine DMF.
A Cinnarizine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cinnarizine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cinnarizine suppliers with CEP (COS) on PharmaCompass.
A Cinnarizine written confirmation (Cinnarizine WC) is an official document issued by a regulatory agency to a Cinnarizine manufacturer, verifying that the manufacturing facility of a Cinnarizine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cinnarizine APIs or Cinnarizine finished pharmaceutical products to another nation, regulatory agencies frequently require a Cinnarizine WC (written confirmation) as part of the regulatory process.
click here to find a list of Cinnarizine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cinnarizine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cinnarizine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cinnarizine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cinnarizine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cinnarizine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cinnarizine suppliers with NDC on PharmaCompass.
Cinnarizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cinnarizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cinnarizine GMP manufacturer or Cinnarizine GMP API supplier for your needs.
A Cinnarizine CoA (Certificate of Analysis) is a formal document that attests to Cinnarizine's compliance with Cinnarizine specifications and serves as a tool for batch-level quality control.
Cinnarizine CoA mostly includes findings from lab analyses of a specific batch. For each Cinnarizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cinnarizine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cinnarizine EP), Cinnarizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cinnarizine USP).
